India to Turkey: Ras Export Trade Route

The India to Turkey Ras corridor is one of India's established pharmaceutical export routes, with 218 shipments documented worth a combined $10.5M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's ras manufacturing sector.

Across 40 active suppliers, the average shipment value stands at $47.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with ras's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 34.2%, placing it at rank #10 among India's top ras export destinations globally.

On the import side, key buyers of Indian ras in Turkey include ABDI IBRAHIM ILAC SANAYI VE TICARET, ABDI IBRAHIM ILAC SANAYI VE TICARET SANAYIMAH TUNC, WHITE INTERNATIONAL GROUP LOGISTIC and 56 others. ABDI IBRAHIM ILAC SANAYI VE TICARET is the single largest importer with 22 shipments valued at $8.2M USD.

India's ras exports to Turkey are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 28 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 40 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, SANTOZ LIFECARE, M T MADON EXPORTS — together account for 97% of total trade value on this route. The average shipment value of $47.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as canhera-150- trastuzumab-1s-turkey b/n 7802307 and canhera-150- trastuzumab-1s-turkey b/n 7802325, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ABDI IBRAHIM ILAC SANAYI VE TICARET is the largest importer with 22 shipments worth $8.2M USD — representing 78% of all ras imports from India on this route. A total of 59 buyers are active on this corridor.